Nine To Noon cover image

What needs to be done to protect the use of genetic testing

Nine To Noon

00:00

Precision cancer treatment: PARP inhibitors

Andrew uses ovarian cancer to show how genetic tests identify patients who benefit from targeted PARP inhibitor drugs.

Play episode from 03:43
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app